Video

Managing The Hype: How Long Does It Take To Change The World?

Source: Cytiva

There’s a spectrum between incremental change and revolutionary change. Where do AI and ML technologies in biotech fall on that spectrum? Our guest experts, EVQLV CEO and Co-Founder Andrew Satz and Recursion President & COO Tina Larson, discuss whether, and when, advanced computational biology tools might drive step-change advances in the way biotechs discover and develop therapeutics in this segment from the Bioprocess Online Live event, How Computational Biology Speeds Drug Discovery, Development.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva